Not applicableNot Yet RecruitingNCT07758127What this trial is testingUpdates and Insights on HER2 in Breast Cancer in Sohag GovernorateWho this might be right forHER2 Status in Breast Cancer Sohag University 100
Testing effectiveness (Phase 2)UnknownNCT04318223What this trial is testingPalbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal TherapyWho this might be right forMetastatic Breast CancerLocally Advanced Breast Cancer Consorzio Oncotech 168
Early research (Phase 1)Study completedNCT03930680What this trial is testingPrevention of Heart Failure Induced by Doxorubicin With Early Administration of DexrazoxaneWho this might be right forDegradation of Top2b and Top2a in Human by DexrazoxaneTime Course and Degradation of Top2b in Human by DexrazoxaneEffects of Dexrazoxane on Healthy Human University of Arkansas 25
Testing effectiveness (Phase 2)Study completedNCT00284180What this trial is testingVinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast CancerWho this might be right forBreast NeoplasmsBreast Cancer SCRI Development Innovations, LLC 32
Early research (Phase 1)Study completedNCT05585034What this trial is testingPhase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid TumorsWho this might be right forHead and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more Xencor, Inc. 60
Early research (Phase 1)Looking for participantsNCT06784193What this trial is testingPhase 1 Study of OP-3136 in Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic ER+ HER2- Breast Cancer (mBC)Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC)+3 more Olema Pharmaceuticals, Inc. 180
Large-scale testing (Phase 3)Ended earlyNCT00968968What this trial is testingContinued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab AloneWho this might be right forCancer Novartis Pharmaceuticals 37
Early research (Phase 1)WithdrawnNCT01741597What this trial is testingDynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or LungWho this might be right forAcinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasLiver Metastases+5 more City of Hope Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT03519178What this trial is testingPF-06873600 in People With CancerWho this might be right forHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer Pfizer 155
Post-approval studies (Phase 4)Not Yet RecruitingNCT07630948What this trial is testingAdherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast CancerWho this might be right forBreast CancerAdherence, Medication Institute of Oncology Ljubljana 90
Not applicableStudy completedNCT00897468What this trial is testingDeveloping Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast CancerWho this might be right forBreast Cancer Vanderbilt-Ingram Cancer Center 26
Early research (Phase 1)Study completedNCT03364348What this trial is testing4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast CancerWho this might be right forHER2 Positive Breast CarcinomaRecurrent Breast CarcinomaStage III Breast Cancer+4 more George W. Sledge Jr. 18
Not applicableStudy completedNCT05412459What this trial is testing99mTc-DARPinG3-based HER2 Expression Molecular Imaging in HER2-positive Breast Cancer During Chemo+Targeted TherapyWho this might be right forHER2-positive Breast CancerFemale Tomsk National Research Medical Center of the Russian Academy of Sciences 15
Early research (Phase 1)Looking for participantsNCT04222413What this trial is testingMetarrestin (ML-246) in Subjects With Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorsMetastatic Pancreatic CancerPediatric Solid Tumor+3 more National Cancer Institute (NCI) 116
Testing effectiveness (Phase 2)Study completedNCT00444535What this trial is testingLapatinib and Bevacizumab for Metastatic Breast CancerWho this might be right forNeoplasms, Breast Novartis Pharmaceuticals 52
Not applicableStudy completedNCT03244943What this trial is testingCytokine Profiles in Breast Cancer Patients Undergoing ChemotherapyWho this might be right forMammary Neoplasm, HumanPeriodontal DiseasesChemotherapy Effect University of Sao Paulo 40
Not applicableStudy completedNCT01372917What this trial is testingEvaluating AlloMax in Immediate Expander-Based Breast Reconstruction StudyWho this might be right forMalignant Neoplasm of the BreastAcquired Absence of the Breast National Center for Plastic Surgery, Virginia 39
Testing effectiveness (Phase 2)Study completedNCT03878823What this trial is testingSafety and Pharmacokinetics of ODM-209Who this might be right forProstate Cancer MetastaticAdvanced Breast CancerCastration-resistant Prostate Cancer+1 more Orion Corporation, Orion Pharma 38
Early research (Phase 1)UnknownNCT06256055What this trial is testingPhase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid TumorsWho this might be right forMalignant MesotheliomaColorectal CancerBile Duct Cancer+4 more UTC Therapeutics Inc. 24
Early research (Phase 1)Ended earlyNCT00301106What this trial is testingBiological Therapy in Treating Women With Breast Cancer That Has Spread to the LiverWho this might be right forBreast CancerMetastatic Cancer Max Sung 2